Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23619124)

1.

Nonmelanoma skin cancer in childhood after hematopoietic stem cell transplant: a report of 4 cases.

Rork JF, Margossian SP, Nambudiri VE, Huang JT.

J Pediatr Hematol Oncol. 2014 Apr;36(3):224-7. doi: 10.1097/MPH.0b013e31828e5d96.

PMID:
23619124
2.

Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.

McLaughlin JM, Equils O, Somerville KT, Aram JA, Schlamm HT, Welch VL, Mardekian J, Barbers RG.

Transpl Infect Dis. 2013 Aug;15(4):329-43. doi: 10.1111/tid.12063. Epub 2013 Mar 12.

PMID:
23489832
3.

Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.

Cowen EW, Nguyen JC, Miller DD, McShane D, Arron ST, Prose NS, Turner ML, Fox LP.

J Am Acad Dermatol. 2010 Jan;62(1):31-7. doi: 10.1016/j.jaad.2009.09.033. Epub 2009 Nov 6.

4.

Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation.

Leisenring W, Friedman DL, Flowers ME, Schwartz JL, Deeg HJ.

J Clin Oncol. 2006 Mar 1;24(7):1119-26. Epub 2006 Feb 6.

5.

Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.

Tessari G, Naldi L, Boschiero L, Nacchia F, Fior F, Forni A, Rugiu C, Faggian G, Sassi F, Gotti E, Fiocchi R, Talamini G, Girolomoni G.

Arch Dermatol. 2010 Mar;146(3):294-9. doi: 10.1001/archdermatol.2009.377.

PMID:
20231501
6.

Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.

Zavos G, Karidis NP, Tsourouflis G, Bokos J, Diles K, Sotirchos G, Theodoropoulou E, Kostakis A.

Int J Dermatol. 2011 Dec;50(12):1496-500. doi: 10.1111/j.1365-4632.2011.04939.x. Epub 2011 Jul 26.

PMID:
21790552
7.

Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.

Zwald FO, Spratt M, Lemos BD, Veledar E, Lawrence C, Marshall Lyon G, Chen SC.

Dermatol Surg. 2012 Aug;38(8):1369-74. doi: 10.1111/j.1524-4725.2012.02418.x. Epub 2012 May 2.

PMID:
22551390
8.

Nonmelanoma skin cancer after liver transplantation. Study of risk factors.

Herrero JI, España A, Quiroga J, Sangro B, Pardo F, Alvárez-Cienfuegos J, Prieto J.

Liver Transpl. 2005 Sep;11(9):1100-6.

9.

Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study.

Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, Meadows AT, Hutchinson R, Dreyer ZE, Robison LL, Mertens AC.

J Clin Oncol. 2005 Jun 1;23(16):3733-41.

10.

Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.

Feist A, Lee R, Osborne S, Lane J, Yung G.

J Heart Lung Transplant. 2012 Nov;31(11):1177-81. doi: 10.1016/j.healun.2012.05.003. Epub 2012 Jul 27.

PMID:
22841559
11.

First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.

Mackenzie KA, Wells JE, Lynn KL, Simcock JW, Robinson BA, Roake JA, Currie MJ.

Nephrol Dial Transplant. 2010 Jan;25(1):300-6. doi: 10.1093/ndt/gfp482. Epub 2009 Sep 25.

12.

Voriconazole phototoxicity in children: a retrospective review.

Sheu J, Hawryluk EB, Guo D, London WB, Huang JT.

J Am Acad Dermatol. 2015 Feb;72(2):314-20. doi: 10.1016/j.jaad.2014.10.023. Epub 2014 Dec 3.

PMID:
25481710
13.

A population-based study of skin cancer incidence and prevalence in renal transplant recipients.

Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM.

Br J Dermatol. 2006 Mar;154(3):498-504.

PMID:
16445782
14.

Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.

Bernat García J, Morales Suárez-Varela M, Vilata JJ, Marquina A, Pallardó L, Crespo J.

Acta Derm Venereol. 2013 Jul 6;93(4):422-7. doi: 10.2340/00015555-1525.

16.

Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.

Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socié G, Peraldi MN.

Biol Blood Marrow Transplant. 2009 Oct;15(10):1251-7. doi: 10.1016/j.bbmt.2009.05.016.

17.

Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.

Carroll RP, Ramsay HM, Fryer AA, Hawley CM, Nicol DL, Harden PN.

Am J Kidney Dis. 2003 Mar;41(3):676-83.

PMID:
12612993
18.

Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.

Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rödler S, Ankersmit J, Zuckermann A, Tschachler E.

Int J Dermatol. 2008 Sep;47(9):918-25. doi: 10.1111/j.1365-4632.2008.03711.x.

PMID:
18937654
19.

High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.

Chen MH, Chang PM, Li WY, Hsiao LT, Hong YC, Liu CY, Gau JP, Liu JH, Chen PM, Chiou TJ, Tzeng CH.

Bone Marrow Transplant. 2011 Apr;46(4):567-72. doi: 10.1038/bmt.2010.163. Epub 2010 Jul 12.

PMID:
20622906
20.

Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients.

Ramsay HM, Reece SM, Fryer AA, Smith AG, Harden PN.

Transplantation. 2007 Aug 15;84(3):437-9.

PMID:
17700173
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk